文献速递炎症性肠病

系统综述与荟萃分析:炎症性肠病妊娠不良结局风险

Systematic review with meta-analysis: risk of adverse pregnancy-related outcomes in inflammatory bowel disease.
PubMed 文献 · Aliment Pharmacol Ther · 2020-01-07

该系统综述与荟萃分析检索Medline、Embase和Cochrane图书馆至2019年5月,纳入53项研究(7917例IBD妊娠与3253例健康对照妊娠),比较IBD患者与健康对照的母体、胎盘及产科不良结局。结果显示IBD患者剖宫产、妊娠期糖尿病及足月前胎膜早破风险更高,但胎盘疾病发生率仍较低,抗TNF治疗未与不良妊娠结局相关。

要点

  • IBD妊娠剖宫产风险升高(OR 1.79),溃疡性结肠炎显著而克罗恩病未达显著。
  • IBD妊娠期糖尿病风险升高(OR 2.96),足月前胎膜早破风险明显升高(OR 12.10)。
  • 抗TNF治疗未增加绒毛膜羊膜炎、早期妊娠丢失或前置胎盘风险。

核心结论

  • IBD患者妊娠期糖尿病和足月前胎膜早破更常见,但胎盘疾病发生率仍低。

研究设计与样本

  • 系统综述与荟萃分析,检索Medline、Embase和Cochrane图书馆至2019年5月,纳入53项研究(7917例IBD妊娠和3253例健康对照妊娠)。

主要发现

  • IBD患者剖宫产较健康对照更常见(OR 1.79,95%CI 1.16-2.77),UC显著(OR 1.80,95%CI 1.21-2.90),CD未达显著(OR 1.48,95%CI 0.94-2.34)。
  • 妊娠期糖尿病在IBD中更常见(OR 2.96,95%CI 1.47-5.98)。
  • 足月前胎膜早破在IBD中更常见(OR 12.10,95%CI 2.15-67.98),早期妊娠丢失未见显著增加(OR 1.63,95%CI 0.49-5.43)。

关键数值与推荐

  • 胎盘疾病发生率:子痫前期2.0%(95%CI 0.9%-3.1%),胎盘早剥3.3%(95%CI 0%-7.2%),前置胎盘0.5%(95%CI 0.2%-0.9%),绒毛膜羊膜炎0.3%(95%CI 0%-0.5%)。
  • 抗TNF治疗与绒毛膜羊膜炎(OR 1.12,95%CI 0.16-7.67)、早期妊娠丢失(OR 1.49,95%CI 0.83-2.64)、前置胎盘(OR 1.58,95%CI 0.30-8.47)均无显著关联。

临床怎么用

  • 对IBD妊娠患者应关注妊娠期糖尿病筛查及胎膜早破风险,抗TNF治疗期间妊娠未见上述不良结局信号。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The effect of inflammatory bowel disease (IBD) on pregnancy-related outcomes remains unknown. AIM: To determine the risk of adverse maternal, placental and obstetric outcomes in IBD METHODS: We searched Medline, Embase and Cochrane library through May 2019 for studies reporting adverse maternal, placental and obstetric outcomes in patients with IBD. Odds ratios (OR) with 95% confidence intervals (CI) were calculated for these outcomes in patients with IBD compared to healthy controls. RESULTS: Fifty-three studies were included (7917 IBD pregnancies and 3253 healthy control pregnancies). Caesarean delivery was more common in patients with IBD compared to healthy controls (OR 1.79, 95% CI, 1.16-2.77). This remained significant for UC (OR 1.80, 95% CI, 1.21-2.90) but not CD (OR 1.48, 95% CI, 0.94-2.34). Similarly, gestational diabetes occurred more commonly in IBD (OR 2.96, 95% CI, 1.47-5.98). The incidences of placental diseases were 2.0% (95% CI, 0.9%-3.1%) for pre-eclampsia, 3.3% (95% CI, 0%-7.2%) for placental abruption, 0.5% (95% CI, 0.2%-0.9%) for placenta previa and 0.3% (95% CI, 0%-0.5%) for chorioamnionitis. Patients with IBD were more likely to experience preterm prelabour rupture of membranes (OR 12.10, 95% CI, 2.15-67.98), but not early pregnancy loss (OR 1.63, 95% CI 0.49-5.43). Anti-tumour necrosis factor therapy was not associated with chorioamnionitis (OR 1.12, 95% CI, 0.16-7.67), early pregnancy loss (OR 1.49, 95% CI, 0.83-2.64) or placenta previa (OR 1.58, 95% CI, 0.30-8.47). CONCLUSIONS: Gestational diabetes and preterm prelabour rupture of membranes occurs more commonly in patients with IBD, although the incidence of placental diseases remains low.

来源:Aliment Pharmacol Ther,查看原文。版权归原作者所有。

引用

  1. Tandon P, Govardhanam V, Leung K, et al. Systematic review with meta-analysis: risk of adverse pregnancy-related outcomes in inflammatory bowel disease. Aliment Pharmacol Ther. 2020. PMID: 31912546. doi:10.1111/apt.15587

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。